| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/25/2008 | WO2008066776A3 Methods for treating hypercholesterolemia |
| 09/25/2008 | US20080235817 Artificial mammalian chromosome |
| 09/25/2008 | US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors |
| 09/25/2008 | US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 09/25/2008 | US20080234222 Polylysine and polyethylenimine complex of a therapeutic nucleic acid, a polycationic block copolymer, and a polyanionic block copolymer; dosage form for delivering the nucleic acid to a cell in vivo |
| 09/25/2008 | US20080234220 Reducing flavivirus or Hepatitis virus replication in vitro or vivo by inhibiting activity of a microRNA; administering an antisense oligonucleotide complementary to microR-122 |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234217 Double stranded nucleotide sequences for use as tools in tissue targeted gene expression inhibition and treatment of cancer, vascular, neuronal and endocrine diseases |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233098 For regulation of growth of neurons in the Central Nervous System; delivering a dominant negative RhoA to the nerve growth environment of the patient, stimulating axon growth of a damaged neuronal axon; exoenzyme C3( ADP-ribosyltransferase) or Y27632 |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233094 Attenuated Salmonella Enterica Serovar Paratyphi a and Uses Thereof |
| 09/25/2008 | US20080233089 Modified Cells Expressing a Protein That Modulates Activity of Bhlh Proteins, and Uses Thereof |
| 09/25/2008 | US20080233088 Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | CA2684569A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | CA2684321A1 Compositions comprising pkac fragments and uses thereof for inhibiting akt1, p70s6k or abl activity |
| 09/25/2008 | CA2680876A1 Oral vaccine |
| 09/25/2008 | CA2680368A1 A method of treating malignant mesothelioma |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | CN101273122A Use of common gamma chain cytokines for the genetic modification of memory T lymphocytes |
| 09/24/2008 | CN101270363A DNA vaccine carrier of single-chain RNA expression with immune activation function and uses thereof |
| 09/24/2008 | CN101270360A XAGE-1 gene and application of its expression production in tumour treatment and diagnosis |
| 09/24/2008 | CN101270358A MiRNA sequence and uses thereof |
| 09/24/2008 | CN101270354A Expression and application of B7-H4 in lung cancer cell |
| 09/24/2008 | CN101270168A Hyaluronic acid stem grafting polyethylene imine copolymer, preparing method and application as genophore |
| 09/24/2008 | CN101270160A Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/24/2008 | CN101269013A Method for preparing polymer microsphere |
| 09/24/2008 | CN100420749C Application of ShRNA pointed at HBV gene in inhibiting hepatitis B virus duplication |
| 09/24/2008 | CN100420742C Oncolytic adenovirus with target for liver cancer and its preparation method and use |
| 09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427488 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/23/2008 | US7427482 screening for nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents |
| 09/23/2008 | US7427395 a Sendai virus envelope vector incorporated with anticancer or antitumor agents |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2372992C Selenium-containing pro-drugs for cancer therapy |
| 09/23/2008 | CA2335393C Liposomal encapsulated nucleic acid-complexes |
| 09/23/2008 | CA2294598C Transcriptional activators with graded transactivation potential |
| 09/23/2008 | CA2259179C Emulsion formulations for hydrophilic active agents |
| 09/23/2008 | CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy |
| 09/23/2008 | CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 09/23/2008 | CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1 |
| 09/18/2008 | WO2008113078A1 Oncolytic vaccinia virus cancer therapy |
| 09/18/2008 | WO2008112787A2 Method and apparatus of low strength electric field network-mediated delivery of therapeutics in solid organs |
| 09/18/2008 | WO2008112730A1 A method for using lowstrength electric field network (lsen) and immunosuppressive strategies to mediate immune responses |
| 09/18/2008 | WO2008112701A2 G-substrate for the treatment and prevention of parkinson's disease |
| 09/18/2008 | WO2008112525A2 Treatment of lysosomal storage diseases |
| 09/18/2008 | WO2008112297A2 Methods of treating cancer by interfering with igf-i receptor signaling |
| 09/18/2008 | WO2008112278A2 Methods and compositions for modulating insulin secretion and glucose metabolism |
| 09/18/2008 | WO2008112218A2 Li-rnai involved li suppression in cancer immunotherapy |
| 09/18/2008 | WO2008111990A1 Rare cell analysis using sample splitting and dna tags |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008110624A2 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 09/18/2008 | WO2008110356A2 Protein pi 16 secreted from the heart and uses thereof |
| 09/18/2008 | WO2008109953A1 Method for treating cancer via the mucosal administration of interleukin |
| 09/18/2008 | WO2008095033A3 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 09/18/2008 | WO2008088895A9 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma |
| 09/18/2008 | WO2008087419A3 Animal model for adhd |
| 09/18/2008 | WO2008071771A3 Inhibition of gpr4 |
| 09/18/2008 | WO2008066744A9 Methods and compositions for treating and preventing spinal cord injury and other neuronal disease or injury |
| 09/18/2008 | WO2008029276A8 Compositions and methods for the treatment of ophthalmic disease |
| 09/18/2008 | US20080227956 Novel morphogenic protein compositions of matter |
| 09/18/2008 | US20080227740 Compositions and Methods for Elimination of Unwanted Cells |
| 09/18/2008 | US20080227736 Used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications |
| 09/18/2008 | US20080227705 Apoptosis-inducing agent and method for inducing apoptosis |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227694 Protein composed of sequence number 1 or 2; proteasome and polyubiquitin chain inhibitors; interaction with ZNF216 and/or AWP1 |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227138 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226677 Recombinant virus vector for gene transfer into lymphoid cells |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226615 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226611 Using vector transformation to generate transgenic connective tissues for use in treatment of degenerative joint diseases |
| 09/18/2008 | US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |